サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：バイオシミラーの世界市場（2022年～2028年）：COVID-19の影響分析、製品別、用途別、地域別 - 業界分析、市場規模、市場シェア、予測
市場調査レポート
商品コード
1182887

バイオシミラーの世界市場（2022年～2028年）：COVID-19の影響分析、製品別、用途別、地域別 - 業界分析、市場規模、市場シェア、予測

Biosimilars Market with COVID-19 Impact Analysis, By Product, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2022-2028
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 365 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
バイオシミラーの世界市場（2022年～2028年）：COVID-19の影響分析、製品別、用途別、地域別 - 業界分析、市場規模、市場シェア、予測
出版日: 2023年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 365 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオシミラーの市場規模は、2021年に311億760万米ドルとなり、2022年～2028年の予測期間中に16.9％のCAGRで拡大すると予想されています。

当レポートでは、世界のバイオシミラー市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 バイオシミラー市場：概要

第2章 エグゼクティブサマリー

  • 市場内訳
    • 製品別
    • 用途別
    • 国別
    • 地域別
  • 競合洞察

第3章 バイオシミラー市場：主要な動向

  • 市場促進要因
    • 市場促進要因の影響分析
  • 市場抑制要因
    • 市場抑制要因の影響分析
  • 市場機会
  • 市場の今後の動向

第4章 バイオシミラー：業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制の枠組みの分析

第5章 バイオシミラー市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 バイオシミラー市場：情勢

  • 市場シェア分析（2021年）
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 バイオシミラー市場：製品別

  • 概要

第8章 バイオシミラー市場：用途別

  • 概要

第9章 バイオシミラー市場：地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 バイオシミラー業界：主要ベンダー分析

  • 競合ダッシュボード
  • 企業プロファイル
    • Eli Lilly and Company
    • Pfizer Inc.
    • Celltrion Healthcare
    • Novartis AG
    • Viatris Inc. (Mylan)
    • Samsung Bioepis Co. Ltd
    • Stada Arzneimittel AG
    • Teva Pharmaceutical Industries Ltd
    • Intas Pharmaceutical Ltd
    • Biocon Limited
    • LG Life Sciences (LG Chem)
    • Amgen Inc.
    • Dr. Reddy's Laboratories
    • Coherus Biosciences Inc.
    • Biocad

第11章 アナリストの包括的展望

第12章 付録

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biosimilars Market: Product Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Biosimilars Market, by Product 2017-2028 (USD Million)
  • TABLE Biosimilars Market: Regional snapshot (2021)
  • TABLE Biosimilars Market: Application Snapshot (2021)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biosimilars Market, by Application 2017-2028 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biosimilars Market, by Region 2017-2028 (USD Million)
  • TABLE North America Biosimilars Market, by Country, 2017-2028 (USD Million)
  • TABLE North America Biosimilars Market, by Product, 2017-2028 (USD Million)
  • TABLE North America Biosimilars Market, by Application, 2017-2028 (USD Million)
  • TABLE Europe Biosimilars Market, by Country, 2017-2028 (USD Million)
  • TABLE Europe Biosimilars Market, by Product, 2017-2028 (USD Million)
  • TABLE Europe Biosimilars Market, by Application, 2017-2028 (USD Million)
  • TABLE Asia Pacific Biosimilars Market, by Country, 2017-2028 (USD Million)
  • TABLE Asia Pacific Biosimilars Market, by Product, 2017-2028 (USD Million)
  • TABLE Asia Pacific Biosimilars Market, by Application, 2017-2028 (USD Million)
  • TABLE Latin America Biosimilars Market, by Country, 2017-2028 (USD Million)
  • TABLE Latin America Biosimilars Market, by Product, 2017-2028 (USD Million)
  • TABLE Latin America Biosimilars Market, by Application, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Biosimilars Market, by Country, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Biosimilars Market, by Product, 2017-2028 (USD Million)
  • TABLE Middle East and Africa Biosimilars Market, by Application, 2017-2028 (USD Million)

List of Figures

  • FIGURE Biosimilars Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2021
  • FIGURE Product segment market share analysis, 2021 & 2028
  • FIGURE Product segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Application segment market share analysis, 2021 & 2028
  • FIGURE Application segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Regional segment market share analysis, 2021 & 2028
  • FIGURE Regional segment market size forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE North America Biosimilars Market share and leading players, 2021
  • FIGURE Europe Biosimilars Market share and leading players, 2021
  • FIGURE Asia Pacific Biosimilars Market share and leading players, 2021
  • FIGURE Latin America Biosimilars Market share and leading players, 2021
  • FIGURE Middle East and Africa Biosimilars Market share and leading players, 2021
  • FIGURE North America market share analysis by country, 2021
  • FIGURE U.S. Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Canada Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Europe Biosimilars Market share analysis by country, 2021
  • FIGURE Germany Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Spain Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Italy Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE France Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE UK Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Russia Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Netherlands Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Sweden Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Poland Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Rest of the Europe Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Asia Pacific Biosimilars Market share analysis by country, 2021
  • FIGURE India Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE China Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Japan Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE South Korea Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Australia Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Thailand Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Indonesia Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Phillipines Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Rest of APAC Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Latin America Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Latin America Biosimilars Market share analysis by country, 2021
  • FIGURE Brazil Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Mexico Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Argentina Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Colombia Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Rest of LATAM Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Middle East and Africa Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Middle East and Africa Biosimilars Market share analysis by country, 2021
  • FIGURE Saudi Arabia Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE United Arab Emirates Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Israel Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Turkey Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Algeria Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Egypt Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
  • FIGURE Rest of MEA Biosimilars Market size, forecast and trend analysis, 2017 to 2028 (USD Million)
目次
Product Code: ANV1033

REPORT HIGHLIGHT

Biosimilars Market size was valued at USD 31,107.6 Million in 2021, expanding at a CAGR of 16.9% from 2022 to 2028.

The drugs known as biosimilars are derived from live organisms, though they can be produced in a variety of methods and using relatively different materials. Biosimilars are fundamentally different from generic medicines due to the complexity and high expense of their development as well as their molecular size and structure.

Market Dynamics

The rising elderly population and the rising incidence of chronic diseases, coupled with the quicker regulatory approval procedure are supporting the biosimilar market growth. The cost of biosimilars is more than 20% lower than its branded counterparts. As a result, patients can obtain highly effective treatments while also saving money. When compared to innovative biologics, biosimilars have cheaper Expenses. Because research expenses are lower, biosimilars are less expensive.

Reduced-priced biosimilars frequently cause the costs of reference biologics to rise due to manufacturer pricing rivalry. In the upcoming years, demand for biosimilar medicines is likely to rise because of their high cost-to-benefit ratio. The growing use of these medications throughout the world could lower direct spending on biologics. To acquire a competitive edge in the development, production, or sale of their products, numerous pharmaceutical companies are pursuing strategic partnerships, collaborations, and acquisitions. The partnerships want to give patients access to high-quality, affordable medicines.

COVID-19 Analysis:

Pharmaceutical companies specializing in the development of biosimilars face a substantial challenge. Additionally, according to a study titled "Impact of COVID-19 on Cancer Care: A Global Collaborative Study" that was released in September 2020, almost 90% of cancer care facilities encountered difficulties providing standard cancer care due to a variety of factors, including preventive measures, a lack of personal protective equipment, and staff shortages brought on by COVID-19.

Segmentation Analysis:

The Global Biosimilars Market is segmented based on Product, Application, and Region.

Based on the product, the market is segmented into oncology, blood disorders, growth hormonal deficiency, chronic and autoimmune disorders, and others. During the projection period, the oncology segment is likely to witness strong revenue CAGR growth. As they add competition to the drug development process, biosimilars have a number of potential advantages in the treatment of cancer. Patients who must pay for the original products benefit greatly from the use of biosimilars in terms of financial savings. The term "biologics" refers to a broad range of goods, including vaccines, hormones, anti-allergy drugs, and blood and blood components. Oncology holds a sizeable portion of the market due to the introduction of new chemical and biological carcinogens that are raising the incidence of cancer. As a result of advancements in medical technology, doctors may now successfully cure patients who were diagnosed at a later stage and return them to normalcy. Cancer, however, spreads throughout the body as it progresses, reducing the range of available treatments. The cost of treatment for many cancer patients is reduced by the use of biosimilars, making it more accessible and affordable.

Regionally, the Asia Pacific region is expected to grow at the highest CAGR over the forecast period due to the presence of various emerging players in the region. The increasing geriatric population in Asia-Pacific is associated with a high healthcare expenditure burden, and the market segment demands cost-effective options (i.e. biosimilars), which can augment market development. An increasing number of cancer patients in this region and the lack of medical infrastructure especially for cancer patients are creating opportunities for private manufacturers.

Recent Development:

In May 2022, Amneal Pharmaceuticals, Inc. received approval from the US Food and Drug Administration ("FDA") for a Biologics License Application ("BLA") for pegfilgrastim-pbbk, a biosimilar to Neulasta. The product will be sold under the brand name FYLNETRA.

Key features of the study:

  • This proposed research study on the Biosimilars market provides market size (US$ Million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
  • The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for the Biosimilars market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biosimilars market
  • The impact of COVID-19 on the Biosimilars market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Biosimilars market post-COVID will also be covered.
  • To give the users of this report a comprehensive view of the Biosimilars market, we have also included a competitive landscape and key innovator analysis for the Biosimilars market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Biosimilars market.
  • In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.
  • The global Biosimilars market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOSIMILARS MARKET KEY PLAYERS

  • Eli Lilly and Company
  • Pfizer Inc.
  • Celltrion Healthcare
  • Novartis AG
  • Viatris Inc. (Mylan)
  • Samsung Bioepis Co. Ltd
  • Stada Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd
  • Intas Pharmaceutical Ltd
  • Biocon Limited
  • LG Life Sciences (LG Chem)
  • Amgen Inc.
  • Dr. Reddy's Laboratories
  • Coherus Biosciences Inc.
  • Biocad

GLOBAL BIOSIMILARS MARKET, BY PRODUCT

  • Recombinant Non-Glycosylated Proteins
  • Recombinant Glycosylated Proteins

GLOBAL BIOSIMILARS MARKET, BY APPLICATION

  • Oncology
  • Blood Disorders
  • Growth Hormonal Deficiency
  • Chronic and Autoimmune Disorders
  • Others

GLOBAL BIOSIMILARS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

TABLE OF CONTENT

1. Biosimilars Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biosimilars Market Snippet by Product
    • 2.1.2. Biosimilars Market Snippet by Application
    • 2.1.3. Biosimilars Market Snippet by Country
    • 2.1.4. Biosimilars Market Snippet by Region
  • 2.2. Competitive Insights

3. Biosimilars Key Market Trends

  • 3.1. Biosimilars Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biosimilars Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biosimilars Market Opportunities
  • 3.4. Biosimilars Market Future Trends

4. Biosimilars Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biosimilars Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biosimilars Market Landscape

  • 6.1. Biosimilars Market Share Analysis, 2021
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biosimilars Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2021 & 2028 (%)
    • 7.1.2. Recombinant Non-Glycosylated Proteins
    • 7.1.3. Recombinant Glycosylated Proteins

8. Biosimilars Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2021 & 2028 (%)
    • 8.1.2. Oncology
    • 8.1.3. Blood Disorders
    • 8.1.4. Growth Hormonal Deficiency
    • 8.1.5. Chronic and Autoimmune Disorders
    • 8.1.6. Others

9. Biosimilars Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2021 & 2028 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Biosimilars Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Biosimilars Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Biosimilars Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Biosimilars Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Biosimilars Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2017 - 2028 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2017 - 2028, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2017 - 2028 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2017 - 2028 (US$ Million)

10. Key Vendor Analysis- Biosimilars Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Eli Lilly and Company
    • 10.2.2. Pfizer Inc.
    • 10.2.3. Celltrion Healthcare
    • 10.2.4. Novartis AG
    • 10.2.5. Viatris Inc. (Mylan)
    • 10.2.6. Samsung Bioepis Co. Ltd
    • 10.2.7. Stada Arzneimittel AG
    • 10.2.8. Teva Pharmaceutical Industries Ltd
    • 10.2.9. Intas Pharmaceutical Ltd
    • 10.2.10. Biocon Limited
    • 10.2.11. LG Life Sciences (LG Chem)
    • 10.2.12. Amgen Inc.
    • 10.2.13. Dr. Reddy's Laboratories
    • 10.2.14. Coherus Biosciences Inc.
    • 10.2.15. Biocad

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us